Clinical phenotypes and classification algorithm for complex regional pain syndrome
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 13, 2018
- Accepted in final form July 18, 2019
- First Published December 24, 2019.
Article Versions
- Previous version (December 24, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Violeta Dimova, PhD*,
- Myriam Selma Herrnberger, MD*,
- Fabiola Escolano-Lozano, MD,
- Heike Lydia Rittner, MD,
- Eva Vlckova, MD,
- Claudia Sommer, MD,
- Christian Maihöfner, MD and
- Frank Birklein, MD
- Violeta Dimova, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Myriam Selma Herrnberger, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Fabiola Escolano-Lozano, MD,
NONE
NONE
Alnylam, travel expenses to preceptorship (not related to paper topic)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Heike Lydia Rittner, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Grünenthal, Phase III studies CRPS
Supported by the European Commission (602133Â ncRNAPain) 2014-2018.
Supported by Funds from the University Hospital of Wuerzburg.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eva Vlckova, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Czech Ministry of Health (grant number NV18-04-00159, subinvestigator, 2018-2021) (2) Colaborative project of 7th Framework programme of the European Commission (project Nr. 602133, ncRNAPain: Non-coding RNAs in neurogenic and neuropathic pain mechanisms and their application for risk assessment, patient stratification and personalized pain medicine), collaborator, 2013-2017.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Claudia Sommer, MD,
Air Liquide, Alnylam, Akcea, Grünenthal
NONE
CSL Behring Grifols Kedrion Pfizer Inc Sanofi-Genzyme Shire
Academic Editor, PlosOne
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
German Research Foundation (DFG)328/9-1; 328/10-1 Bundesministerium für Bildung und Forschung (BMBF), CMT-Net
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christian Maihöfner, MD and
1, Astellas, Bionorica, Grunenthal, Mundipharma, Novartis
NONE
Allergan, Astellas, Astra-Zeneca, Grunenthal, Lilly, Novartis, Pfizer, Mundipharma, UCB
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Frank Birklein, MD
Alnylam advisor, ongoing Almirall advisor, ongoing Akcea advisor, ongoing
NONE
Pfizer Germany
Neurology, ed board, ongoing European Journal of Pain, field editor, ongoing Pain Medidicin, ed board, ongging The Open Neurology Journal, ed board, ongoing
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Alnylam, IIT
German Research Foundation 2018-2022 Bi 579/11 Bi579/10 European comission, FP7 program, ncRNAPain No. 602133
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (V.D., M.S.H., F.E.-L., F.B.), University Medical Center of the Johannes Gutenberg University Mainz; Departments of Anesthesiology (H.L.R.) and Neurology (C.S.), University Hospital Würzburg, Germany; Central European Institute of Technology and Medical Faculty (E.V.), Masaryk University, Brno; Department of Neurology (E.V.), University Hospital Brno, Czech Republic; and Department of Neurology (C.M.), General Hospital Fürth of the Friedrich-Alexander University Erlangen-Nürnberg, Germany.
- Correspondence
Dr. Dimova violeta.dimova{at}unimedizin-mainz.de
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.